Top-News
USA

Jazz Pharmaceuticals News

Aktie
WKN:  A1JS1K ISIN:  IE00B4Q5ZN47 US-Symbol:  JAZZ
93,32 €
-0,14 €
-0,15%
17:38:18 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
63,13 Mio.
Marktkapitalisierung *
5,90 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 16.09.2023

Jazz Pharmaceuticals News

02.07.24 - Hotstock Investor
Spotbillige Bewertung : Diese Aktie hat einen Platz in Ihrem Portfolio verdient
Diese Aktie hat sich als Marktführer in Europa etabliert und trägt maßgeblich zum Aufschwung und zum allgemeinen Marktwachstum bei. Liebe Leserinnen und Leser, ...
01.07.24 - Hotstock Investor
Riesiges Wachstumspotenzial: Spotbillige Bewertung in einem rasant wachsenden Sektor in Europa!
Cannabis-​Aktien sind der Hammer, die Branche wächst wie Unkraut Diese Aktie hat einen Platz in Ihrem Blütenportfolio verdient Liebe Leserinnen und Leser, angetrieben durch ...
20.06.24 - PR Newswire
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor PR Newswire
15.06.24 - Small- & Micro Cap Investment
Cannabis-Entkriminalisierung in vielen Staaten – TerrAscend, Aurora Cannabis und AbbVie
„Marihuana ist die Heilung einer Nation, Alkohol die Zerstörung“, sagte die Reggae-​Legende Bob Marley einmal. Die Regierungsverantwortlichen fast aller Nationen sahen das zu ...
01.06.24 - PR Newswire
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-​BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract ...
30.05.24 - PR Newswire
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 PR Newswire
29.05.24 - PR Newswire
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire
29.05.24 - PR Newswire
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire
29.05.24 - PR Newswire
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer PR Newswire
22.05.24 - PR Newswire
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism PR Newswire
04.05.24 - Small- & Micro Cap Investment
Marihuana auf dem Vormarsch – TerrAscend, Aurora Cannabis und AbbVie
„Marihuana ist die Heilung einer Nation, Alkohol die Zerstörung“, sagte die Reggae-​Legende Bob Marley einmal. Die Regierungsverantwortlichen fast aller Nationen sahen das zu ...
01.05.24 - PR Newswire
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference PR Newswire
01.05.24 - PR Newswire
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference PR Newswire
01.05.24 - PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance PR Newswire
01.05.24 - PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance PR Newswire
24.04.24 - PR Newswire
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 PR Newswire
17.04.24 - PR Newswire
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 PR Newswire
17.04.24 - PR Newswire
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 PR Newswire
10.04.24 - PR Newswire
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting PR Newswire
02.04.24 - PR Newswire
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer PR Newswire

Newssuche

Videos

newspaper
03.07.24
Technical Trading: Bund Future Long Chance
Bund Future Long Typ: Turbo Open End WKN: VM3CG4 Hebel: 7,32 Laufzeit: OpenEnd Einstieg: Market ... Mehr »